Oncocyte VitaGraft Kidney Transplant Test Receives CMS Coverage
September 11, 2023Precision diagnostics company Oncocyte announced on Tuesday that its VitaGraft kidney transplant test has received Medicare coverage, following a positive decision from Medicare administrative contractor Palmetto. The diagnostic test is based on Bio-Rad’s Droplet Digital PCR and will be covered under MolDx LCD L38568:
Molecular Testing for Solid Organ Allograft Rejection. This is the same LCD covering CareDx’s multimodal HeartCare transplant surveillance service.